Horizon Technology Finance Board Sued Over Monroe Capital Merger Disclosures
HRZN is trading near its 52-week low of $5.705 (14% above the low).
Summary
A class action lawsuit has been filed against Horizon Technology Finance and its board, alleging breaches of fiduciary duty and material omissions in the proxy statement related to the proposed merger with Monroe Capital Corporation.
Key Events · Legal and Risk Events · HRZN
-
Class Action Lawsuit Filed
A verified class action complaint was filed in the Court of Chancery in Delaware against Horizon Technology Finance Corporation and its board of directors.
-
Merger Disclosures Challenged
The lawsuit alleges breaches of fiduciary duties by the board in connection with the proposed merger with Monroe Capital Corporation, specifically citing material omissions in the proxy statement (Form 424B3 filed on January 20, 2026).
-
Alleged Omissions Identified
The complaint claims the proxy fails to disclose HRZN's standalone and pro forma financial projections relied upon by the financial advisor, Oppenheimer, and also omits details of Oppenheimer's past and current fees from Monroe Capital Corporation.
-
Injunction Sought
The plaintiff seeks to enjoin the shareholder vote on the merger until supplemental disclosures are filed to cure the alleged material nondisclosures, or alternatively, seeks damages.
Analysis · HRZN · Unknown
A class action lawsuit has been filed against Horizon Technology Finance and its board, alleging breaches of fiduciary duty and material omissions in the proxy statement related to the proposed merger with Monroe Capital Corporation. The lawsuit specifically challenges the adequacy of disclosures regarding HRZN's financial projections and potential conflicts of interest of the financial advisor, Oppenheimer. This legal action, which seeks to enjoin the shareholder vote until the alleged material omissions are rectified, introduces significant uncertainty and potential delays for the pending merger, which was previously announced on August 7, 2025, and for which a proxy was filed on January 20, 2026. The outcome could impact the merger's terms or its completion, posing a material risk to the transaction.
At the time of this filing, HRZN was trading at $6.53 on NASDAQ in the Unknown sector, with a market capitalization of approximately $298.7M. The 52-week trading range was $5.71 to $9.99. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.